Application 761027

Type
BLA
Sponsor
ACCORD BIOPHARMA INC.

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761027Filkrifilgrastim-laha351(k) BiosimilarRx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FILKRIFILGRASTIM-LAHAINJECTABLE;INJECTION300MCG/0.5MLNoNo
002FILKRIFILGRASTIM-LAHAINJECTABLE;INJECTION480MCG/0.8MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FILKRIFILGRASTIM-LAHAAccord BioPharma Inc.,9c2f9573-08fd-43be-a489-8a5e5d8ab2ff2026-07-10Warnings, Adverse reactionsExact identifier
application number: BLA761027

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84806ORIG 2026-01-21
84779ORIG 2026-01-20